Tempest Therapeutics (TPST) Stock Price, Quote, News & History | Benzinga

Tempest Therapeutics Inc (TPST) Stock Price, Quote, News & History

TPSTNASDAQ

Trade with Public

Trade with Public

$1.09

0.032.83%

At close: Aug 31, 5:00 PM EST

$1.07

-0.02-1.83%

After Hours: 6:17 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$1.06

Close

$1.09

Volume / Avg.

60.83K / 207.25K

Day Range

$1.06 - $1.13

52 Wk Range

0.84 - 12.23

Market Cap

$17.70M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

54

Short Interest

4.65%

Days to Cover

1

Recent Tempest Therapeutics Inc News

Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results

Avi Kapoor

Nasdaq Gains Over 100 Points; Target Trims Earnings Forecast

Avi Kapoor

Why Tempest Therapeutics (TPST) Stock Is Down 45% Today

Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.

Henry Khederian

Partner Content

Biodexa Moves Into Phase 3 With eRapa For FAP With First Patient Enrolled

Partner Content

How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-20.73M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

7.23M

Free Cash Flow (TTM)

-20.73M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-13.50M

Analyst Rating and Forecast

3.1

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$24.81M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-337.61%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.07

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$779.00K

Debt to Equity

-

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

$1.06

Close

$1.09

Volume / Avg.

60.83K / 207.25K

Day Range

$1.06 - $1.13

52 Wk Range

0.84 - 12.23

Market Cap

$17.70M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

54

Short Interest

4.65%

Days to Cover

1

About

Sector

Health Care

Industry

Biotechnology

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic pr...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Tempest Therapeutics (TPST) stock?

A

You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Tempest Therapeutics (TPST) competitors?

A

Other companies in Tempest Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Tempest Therapeutics (TPST) stock?

A

Tempest Therapeutics has a consensus price target of $10.00.

Q

What is the current price for Tempest Therapeutics (TPST)?

A

The stock price for Tempest Therapeutics (NASDAQ: TPST) is $1.07 last updated August 31, 2026 at 6:17 PM EDT.

Q

Does Tempest Therapeutics (TPST) pay a dividend?

A

There are no upcoming dividends for Tempest Therapeutics.

Q

When is Tempest Therapeutics (NASDAQ:TPST) reporting earnings?

A

Tempest Therapeutics does not have any upcoming earnings scheduled.

Q

Is Tempest Therapeutics (TPST) going to split?

A

There is no upcoming split for Tempest Therapeutics.

Q

What sector and industry does Tempest Therapeutics (TPST) operate in?

A

Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.